Lexaria Bioscience Corp (LEXX)

[AgentSmith]

... the company filed an S4 prospectus to re-domicile the company from the U.S. to Canada in an effort to exploit opportunities in the Canadian cannabinoid products sector.”

This answers to my satisfaction the question I've posted on this board a couple of times in the past few weeks - i.e.: Is it possible the conversion was motivated, at least in part, by potential suitors/partners wanting to deal with a "U.S.-free" LXRP?

It's not like "opportunities in the Canadian cannabinoid products sector" haven't been available. The wording clearly suggests, rather, that LXRP's been unable to "exploit" them, and consequently filed the S4.

I figure we'll be in a holding pattern until LXRP's rid itself of any association with the U.S., and then things will (hopefully) get interesting very quickly.